Enterprise Value of Nymox Pharmaceutical Corporation (NYMX) is 146 million

Enterprise value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet. Enterprise value is a popular metric used to value a company for a potential takeover. It is calculated as a sum of the market value of common stock, market value of preferred equity, debt and minority interest, minus total cash and investments.


Source: Investopedia

Enterprise Value
Dec 19Jan 20Feb 20Mar 20Apr 20May 20Jun 20Jul 20Aug 20Sep 20Oct 20Nov 20
123.7 million137.9 million245.7 million192.8 million146 million203.6 million245.4 million259.7 million228.2 million194.1 million179.6 million146 million